| Not Yet Recruiting | Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets Primary Hypertension | Phase 1 | 2026-03-09 |
| Enrolling By Invitation | Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Eve Osteoporosis | Phase 1 | 2025-10-19 |
| Recruiting | Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants Healthy Participants | Phase 4 | 2025-09-06 |
| Not Yet Recruiting | Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients Renal Anemia in Non-dialysis Chronic Kidney Disease | Phase 4 | 2025-08-01 |
| Recruiting | SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population Uncontrolled Hypertension | Phase 1 | 2025-06-09 |
| Not Yet Recruiting | Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants Bioequivalence | Phase 1 | 2025-02-01 |
| Recruiting | SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies Anemia | Phase 2 | 2024-09-14 |
| Completed | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety an Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | 2023-12-19 |
| Completed | A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia Hyperlipidemias | Phase 3 | 2023-10-23 |
| Completed | Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodi Anemia | Phase 3 | 2023-09-19 |
| Completed | A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterole Hypercholesterolemia and Mixed Dyslipidemia | Phase 2 | 2023-06-02 |
| Active Not Recruiting | To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects Pharmacokinetics | Phase 1 | 2023-01-10 |
| Recruiting | Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal A Peripheral Artery Disease | N/A | 2022-05-27 |
| Completed | The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency Type 2 Diabetes Mellitus (T2DM), Renal Insuficiency | Phase 1 | 2022-03-15 |
| Completed | To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontroll Essential Hypertension | Phase 3 | 2021-12-30 |
| Completed | To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk Postmenopausal Women With Osteoporosis | Phase 3 | 2021-12-03 |
| Completed | To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine Essential Hypertension | Phase 3 | 2021-04-29 |
| Recruiting | Sirolimus DEB in Coronary Bifurcation Lesions Coronary Bifurcation Lesions | N/A | 2021-03-18 |
| Completed | SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease Renal Anemia in Non-dialysis Chronic Kidney Disease | Phase 3 | 2020-12-08 |
| Completed | Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults Postmenopausal Osteoporosis | Phase 1 | 2020-08-19 |
| Completed | SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin Diabetes Mellitus, Type 2 | Phase 3 | 2020-05-06 |
| Completed | SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Diabetes Mellitus, Type 2 | Phase 3 | 2019-06-13 |
| Unknown | G56W1 in Women With Postmenopausal Osteoporosis Postmenopausal Osteoporosis | Phase 1 / Phase 2 | 2018-10-01 |
| Unknown | Recombinant SeV-hFGF2/dF Injection for PAOD PAOD - Peripheral Arterial Occlusive Disease, PAD, Critical Limb Ischemia | Phase 1 | 2018-09-05 |
| Unknown | Bivalirudin in Acute Myocardial Infarction Acute Myocardial Infarction | Phase 3 | 2016-11-01 |
| Completed | Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialys Anemia | Phase 3 | 2002-02-22 |